Literature DB >> 16845633

The respiratory pathogen moraxella catarrhalis binds to laminin via ubiquitous surface proteins A1 and A2.

Thuan Tong Tan1, Arne Forsgren, Kristian Riesbeck.   

Abstract

Moraxella catarrhalis is one of the leading causes of exacerbations in chronic obstructive pulmonary disease (COPD). In the present article, we show that moraxella (n=15) binds to the major basement-membrane glycoprotein laminin, which is thickened in the airways of smokers. Using clinical strains of M. catarrhalis and their corresponding ubiquitous surface protein (Usp) A1/A2 mutants, we demonstrate that UspA1 and UspA2 are important for the laminin interaction. Binding assays with recombinant proteins demonstrated that the binding regions are localized within the N-terminal fragments, where both proteins form a globular head. Thus, UspA1/A2-dependent interactions with laminin might promote bacterial adhesion, particularly in smokers with COPD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16845633     DOI: 10.1086/505581

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  21 in total

Review 1.  Potential impact of a Moraxella catarrhalis vaccine in COPD.

Authors:  Antonia C Perez; Timothy F Murphy
Journal:  Vaccine       Date:  2017-02-06       Impact factor: 3.641

2.  Helicobacter pylori AlpA and AlpB bind host laminin and influence gastric inflammation in gerbils.

Authors:  Olga A Senkovich; Jun Yin; Viktoriya Ekshyyan; Carolyn Conant; James Traylor; Patrick Adegboyega; David J McGee; Robert E Rhoads; Sergey Slepenkov; Traci L Testerman
Journal:  Infect Immun       Date:  2011-05-16       Impact factor: 3.441

3.  Moraxella catarrhalis strain O35E expresses two filamentous hemagglutinin-like proteins that mediate adherence to human epithelial cells.

Authors:  Rachel Balder; Jonathan Hassel; Serena Lipski; Eric R Lafontaine
Journal:  Infect Immun       Date:  2007-03-19       Impact factor: 3.441

4.  Comparison of the serological responses to Moraxella catarrhalis immunoglobulin D-binding outer membrane protein and the ubiquitous surface proteins A1 and A2.

Authors:  Thuan Tong Tan; Jens Jørgen Christensen; Morten Hanefeld Dziegiel; Arne Forsgren; Kristian Riesbeck
Journal:  Infect Immun       Date:  2006-09-11       Impact factor: 3.441

5.  Hag mediates adherence of Moraxella catarrhalis to ciliated human airway cells.

Authors:  Rachel Balder; Thomas M Krunkosky; Chi Q Nguyen; Lacey Feezel; Eric R Lafontaine
Journal:  Infect Immun       Date:  2009-08-10       Impact factor: 3.441

6.  Moraxella catarrhalis Binds Plasminogen To Evade Host Innate Immunity.

Authors:  Birendra Singh; Tamim Al-Jubair; Chandrashekar Voraganti; Tobias Andersson; Oindrilla Mukherjee; Yu-Ching Su; Peter Zipfel; Kristian Riesbeck
Journal:  Infect Immun       Date:  2015-06-22       Impact factor: 3.441

7.  An adhesion protein of Salmonella enterica serovar Typhi is required for pathogenesis and potential target for vaccine development.

Authors:  Shubhamoy Ghosh; Krishnendu Chakraborty; Theeya Nagaraja; Surajit Basak; Hemanta Koley; Shanta Dutta; Utpala Mitra; Santasabuj Das
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-07       Impact factor: 11.205

8.  Moraxella catarrhalis binding to host cellular receptors is mediated by sequence-specific determinants not conserved among all UspA1 protein variants.

Authors:  Michael J Brooks; Jennifer L Sedillo; Nikki Wagner; Wei Wang; Ahmed S Attia; Henry Wong; Cassie A Laurence; Eric J Hansen; Scott D Gray-Owen
Journal:  Infect Immun       Date:  2008-08-04       Impact factor: 3.441

9.  Modular arrangement of allelic variants explains the divergence in Moraxella catarrhalis UspA protein function.

Authors:  Michael J Brooks; Jennifer L Sedillo; Nikki Wagner; Cassie A Laurence; Wei Wang; Ahmed S Attia; Eric J Hansen; Scott D Gray-Owen
Journal:  Infect Immun       Date:  2008-08-04       Impact factor: 3.441

Review 10.  Molecular mechanisms of moraxella catarrhalis-induced otitis media.

Authors:  Ferdaus Hassan
Journal:  Curr Allergy Asthma Rep       Date:  2013-10       Impact factor: 4.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.